Opioid Manufacturers to Provide Doctor Training

Share this content:
Opioid Manufacturers to Provide Doctor Training
Opioid Manufacturers to Provide Doctor Training

MONDAY, Oct. 2, 2017 (HealthDay News) -- In an effort to halt the ongoing opioid addiction crisis, U.S. regulators are requiring manufacturers to provide extensive training to doctors, according to a report published by the Associated Press.

Scott Gottleib, M.D., commissioner of the U.S. Food and Drug Administration, noted in a recent blog post that the FDA had informed 74 manufacturers of immediate-release opioids, including hydrocodone/acetaminophen and oxycodone/acetaminophen, that their drugs would be subject to these requirements. However, physicians will not be required to undergo training.

Overall, about 2 million individuals are addicted to prescription opioids in the United States. In 2015, more than 15,000 died of overdoses involving prescription opioids. Manufacturers of long-acting opioids, including oxycodone, have been subject to these requirements since 2012.

Gottleib called the drugs a "potential gateway to addiction" in the blog post.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

White House Unveils New Insurance Option for Small Firms

White House Unveils New Insurance Option for Small ...

Plan expands health reimbursement arrangements so workers can buy individual health coverage

USPSTF Recommends Screening Women for Partner Violence

USPSTF Recommends Screening Women for Partner Violence

Evidence insufficient to support screening for abuse among all elderly or vulnerable adults

Preeclampsia Tied to Increased Risk for Vascular Dementia

Preeclampsia Tied to Increased Risk for Vascular Dementia

Hazard ratios moderately attenuated with adjustment for diabetes, hypertension, CVD

is free, fast, and customized just for you!




Already a member?

Sign In Now »